Expertise in
3
conditions

Dr. Craig F. Laforce

Raleigh, NC
Expertise in
3
conditions
Specialties:Allergy and Immunology
Expertise in
3
conditions
OverviewInsuranceLocationsClinical Research

Overview

Craig Laforce is an Allergy and Immunologist in Raleigh, North Carolina. Dr. Laforce is highly rated in 3 conditions, according to our data. His top areas of expertise are Allergic Rhinitis, Asthma, Eosinophilic Asthma, and Chronic Eosinophilic Pneumonia.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in NC
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

2615 Lake Dr, Suite 301, Raleigh, NC 27607
919-787-5995

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Randomized, Double-blind, Placebo-controlled, Three-period Cross-over Study to Assess the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts (Maleate and Acetate) Delivered Via the Concept1 Inhalation Device in Patients With Asthma
A Randomized, Double-blind, Placebo-controlled, Three-period Cross-over Study to Assess the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts (Maleate and Acetate) Delivered Via the Concept1 Inhalation Device in Patients With Asthma
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: August 19, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label, Single-Center, Single-Dose, 3-Way Crossover Study of the Safety and Pharmacokinetics of Albuterol Administered by the Halix(TM) Albuterol Unit Dose Disposable Inhaler
An Open-label, Single-Center, Single-Dose, 3-Way Crossover Study of the Safety and Pharmacokinetics of Albuterol Administered by the Halix(TM) Albuterol Unit Dose Disposable Inhaler
Enrollment Status: Completed
Publish Date: January 30, 2019
Intervention Type: Drug
Study Phase: Phase 1
Cumulative Dose, 2-Way Crossover Study of the Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler Compared With MDI in Subjects With Asthma
Cumulative Dose, 2-Way Crossover Study of the Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler Compared With MDI in Subjects With Asthma
Enrollment Status: Completed
Publish Date: January 30, 2019
Intervention Type: Drug
Study Phase: Phase 2
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

39 Total Publications

A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design.
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design.
Journal: Journal of asthma and allergy
Published: April 30, 2024
Similar Doctors
Expertise in
8
conditions
Dr. Scott P. Commins
Allergy and Immunology
Expertise in
8
conditions
Dr. Scott P. Commins
Allergy and Immunology

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (20.3 mi)
984-974-1000
Experience:
21+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Commins is an Allergy and Immunologist in Chapel Hill, North Carolina. Dr. Commins has been practicing medicine for over 21 years is highly rated in 8 conditions, according to our data. His top areas of expertise are Alpha-gal Syndrome (AGS), Anaphylaxis, Food Allergy, and Asthma. Dr. Commins is currently accepting new patients.

Expertise in
16
conditions
Dr. Patricia L. Lugar
Allergy and Immunology
Expertise in
16
conditions
Dr. Patricia L. Lugar
Allergy and Immunology

Duke Health Integrated Practice Inc

1821 Hillandale Rd, 
Durham, NC 
 (19.7 mi)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Patricia Lugar is an Allergy and Immunologist in Durham, North Carolina. Dr. Lugar is highly rated in 16 conditions, according to our data. Her top areas of expertise are Common Variable Immune Deficiency, Primary Immunodeficiency (PID), Anaphylaxis, and Selective Deficiency of IgA. Dr. Lugar is currently accepting new patients.

Expertise in
5
conditions
Dr. Cristine C. Radojicic
Allergy and Immunology
Expertise in
5
conditions
Dr. Cristine C. Radojicic
Allergy and Immunology

Duke Health Integrated Practice Inc

40 Duke Medicine Cir, 
Durham, NC 
 (18.2 mi)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Cristine Radojicic is an Allergy and Immunologist in Durham, North Carolina. Dr. Radojicic is highly rated in 5 conditions, according to our data. Her top areas of expertise are Hives, Angioedema, Hereditary Angioedema, and Allergic Rhinitis. Dr. Radojicic is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile